Related Experiment Video

Updated: Jun 24, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Multimodality treatment of germ cell tumors of the mediastinum

Kenneth A Kesler1, Lawrence H Einhorn

  • 1Department of Surgery, Cardiothoracic Division Indiana University School of Medicine, Indianapolis, IN 46202, USA. kkesler@iupui.edu

Thoracic Surgery Clinics
|March 18, 2009
PubMed

Insights

Malignant mediastinal germ cell tumors require tailored chemotherapy and surgery. Non-bleomycin regimens may reduce surgical risks, improving outcomes for these rare cancers.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Cancer Biology

Background:

  • Anterior mediastinal germ cell tumors are rare and biologically diverse.
  • Understanding specific behaviors and treatments for each histologic type is crucial.
  • Primary non-seminomatous germ cell tumors (NSGCT) pose significant challenges.

Purpose of the Study:

  • To review the biologic behaviors and therapeutic strategies for mediastinal germ cell tumors.
  • To highlight the importance of chemotherapy and surgical management for NSGCT.
  • To discuss novel chemotherapy approaches and prognostic factors.

Main Methods:

  • Review of existing literature on mediastinal germ cell tumors.
  • Analysis of treatment outcomes based on chemotherapy regimens and surgical intervention.
  • Identification of prognostic indicators for survival.

Main Results:

  • Non-bleomycin chemotherapy regimens may decrease operative risks associated with residual disease removal.
  • Favorable prognostic subsets identified include those with necrosis or teratoma.
  • Aggressive surgical resection post-cisplatin chemotherapy can lead to long-term survival.

Conclusions:

  • Mediastinal NSGCT management requires a combined approach of chemotherapy and surgery.
  • Continued investigation into chemotherapy strategies is needed to reduce persistent cancer.
  • Young, healthy patients may benefit from aggressive surgical management even with residual disease.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.